Skip to content

SORRENTO THERAPEUTICS, INC.: 10-Q filed 2013-08-13

What SORRENTO THERAPEUTICS, INC. reported in its quarterly report filed 2013-08-13 (fiscal Q2 2013): 30 published measures, 101 facts as tagged in accession 0001193125-13-331373.

This filing

Form
10-Q (quarterly report)
Filed
2013-08-13
Fiscal period
fiscal Q2 2013
Accession
0001193125-13-331373 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All SORRENTO THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-307,788,765USD
At 2012-12-316,781,604USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-305,769,554USD
At 2012-12-316,197,431USD
At 2011-12-314,209,489USD
At 2010-12-315,083,824USD
At 2009-12-313,200,731USD
At 2008-12-31-117,448USD
At 2007-12-31-91,703USD
At 2006-12-31-75,401USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-305,754,579USD
At 2012-12-315,091,312USD
At 2012-06-307,625,277USD
At 2011-12-313,466,549USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-4,736,611USD91
2013-01-01 to 2013-06-30-7,258,950USD181
2006-01-26 to 2013-06-30-18,209,249USD2713
2012-01-01 to 2012-12-31-4,845,308USD366
2012-04-01 to 2012-06-30-943,118USD91
2012-01-01 to 2012-06-30-1,849,244USD182
2011-01-01 to 2011-12-31-3,236,491USD365
2010-01-01 to 2010-12-31-1,808,386USD365
2009-01-01 to 2009-12-31-942,266USD365
2008-01-01 to 2008-12-31-25,745USD366
2007-01-01 to 2007-12-31-16,302USD365
2006-01-26 to 2006-12-31-75,801USD340

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-6,297,172USD181
2006-01-26 to 2013-06-30-15,089,671USD2713
2012-01-01 to 2012-06-30-1,468,850USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-06-30178,198USD181
2006-01-26 to 2013-06-301,899,915USD2713
2012-01-01 to 2012-06-30310,653USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-04-01 to 2013-06-30141,598USD91
2013-01-01 to 2013-06-30275,661USD181
2006-01-26 to 2013-06-302,071,187USD2713
2012-04-01 to 2012-06-30217,135USD91
2012-01-01 to 2012-06-30327,284USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-06-307,188,637USD181
2006-01-26 to 2013-06-3022,689,305USD2713
2012-01-01 to 2012-06-305,938,231USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-228,198USD181
2006-01-26 to 2013-06-30-1,845,055USD2713
2012-01-01 to 2012-06-30-310,653USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-06-301,449,458USD
At 2012-12-311,480,989USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-06-30429,664USD181
2006-01-26 to 2013-06-301,896,303USD2713
2012-01-01 to 2012-06-30203,257USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-4,716,957USD91
2013-01-01 to 2013-06-30-7,231,252USD181
2006-01-26 to 2013-06-30-18,210,445USD2713
2012-04-01 to 2012-06-30-944,874USD91
2012-01-01 to 2012-06-30-1,852,472USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-06-305,922,372USD
At 2012-12-315,251,990USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-04-01 to 2013-06-3021,762USD91
2013-01-01 to 2013-06-3031,690USD181
2006-01-26 to 2013-06-3031,690USD2713

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-06-301,483,945USD
At 2012-12-31584,173USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-06-30735,727USD
At 2012-12-31439,533USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-06-3088,750USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-04-01 to 2013-06-304,858,555USD91
2013-01-01 to 2013-06-307,506,913USD181
2006-01-26 to 2013-06-3020,281,632USD2713
2012-04-01 to 2012-06-301,162,009USD91
2012-01-01 to 2012-06-302,179,756USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-04-01 to 2013-06-302,141,039USD91
2013-01-01 to 2013-06-303,539,716USD181
2006-01-26 to 2013-06-3011,743,042USD2713
2012-04-01 to 2012-06-30917,452USD91
2012-01-01 to 2012-06-301,716,524USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-3013,443,020shares
At 2012-12-3112,004,687shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-06-3023,977,459USD
At 2012-12-3117,146,530USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2013-02-28875,888USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-06-30328,185USD
At 2012-12-3148,625USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-06-30162,807USD
At 2012-12-3166,896USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-06-3075,045USD
At 2012-12-3180,918USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-301,507,516USD91
2013-01-01 to 2013-06-302,757,197USD181
2006-01-26 to 2013-06-307,328,590USD2713
2012-04-01 to 2012-06-30244,557USD91
2012-01-01 to 2012-06-30463,232USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-06-30329,312USD181
2006-01-26 to 2013-06-30808,001USD2713
2012-01-01 to 2012-06-30131,929USD182

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2013-01-01 to 2013-06-30800USD181
2006-01-26 to 2013-06-305,600USD2713
2012-01-01 to 2012-06-30800USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-06-306,354,409USD181
2006-01-26 to 2013-06-3021,805,860USD2713
2012-01-01 to 2012-06-305,934,031USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30296,194USD181
2006-01-26 to 2013-06-30473,140USD2713
2012-01-01 to 2012-06-3051,584USD182

Inspect the source

Entity
SORRENTO THERAPEUTICS, INC. / CIK 0000850261
Captured
SEC response SHA-256
52c2f17674a4b77d02e740899926ba7e57965bff74d27d5e57742ede3dd5745d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000850261.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))